Ming Liu, MD
General Surgery · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 8 carriers
- Offices
- 2
Offices
2 locations
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
32 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Liu’s office at (650) 962-4555 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$55,551
Medicare paid this office $55,551 for 106 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 79 | $13,743 | $110 |
| New patient visit (45+ min) | 62 | $8,391 | $135 |
| Repair of groin hernia (5 years or older) | 12 | $6,023 | $463 |
| Diagnostic exam of anus using an endoscope | 11 | $1,377 | $125 |
| Short return visit (20+ min) | 12 | $1,230 | $62 |
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Hernia repair - groin (open) | 1-10 | None |
| Hernia repair (minimally invasive) | 16 | More than 84% of doctors who do this |
| Mastectomy | 11 | More than 64% of doctors who do this |
| Melanoma (skin cancer) excision | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
106 Original Medicare patients in 2024. Average age 75 · Women 44% · Also on Medicaid 21% · Health risk score 0.85. At or below the middle of the specialty; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 75% · Diabetes 39% · Cancer 33% · Coronary heart disease 25% · Chronic kidney disease 20% · Atrial fibrillation 11%.
The office billed $200,890, Medicare allowed $74,961 and paid $55,551; for 303 services of 40 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 106 | 303 | 75 | 0.85 | $200,890 | $55,551 |
| 2023 | 109 | 340 | 75 | 0.87 | $184,410 | $58,672 |
| 2022 | 127 | 387 | 74 | 0.97 | $183,040 | $67,677 |
| 2021 | 114 | 385 | 74 | 1.06 | $173,220 | $77,930 |
| 2020 | 67 | 165 | 75 | 1.22 | $91,000 | $35,064 |
| 2019 | 97 | 271 | 74 | 1.09 | $143,140 | $54,492 |
| 2018 | 107 | 391 | 74 | 1.09 | $145,775 | $63,087 |
| 2017 | 85 | 351 | 75 | 1.18 | $140,215 | $58,564 |
| 2016 | 87 | 335 | 75 | 1.06 | $126,540 | $58,177 |
| 2015 | 93 | 391 | 75 | 1.12 | $117,000 | $60,731 |
| 2014 | 113 | 449 | 76 | 1.33 | $137,169 | $68,579 |
| 2013 | 136 | 488 | 76 | 1.27 | $156,087 | $77,874 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 59 | $10,447 | $112 |
| New patient visit (45+ min) | 63 | $8,643 | $137 |
| Short return visit (20+ min) | 36 | $6,147 | $81 |
| Diagnostic exam of anus using an endoscope | 11 | $1,384 | $126 |
2022: 5 services
| Return visit (30+ min) | 74 | $13,914 | $110 |
| New patient visit (45+ min) | 77 | $10,774 | $140 |
| Repair of groin hernia (5 years or older) | 12 | $5,702 | $475 |
| Short return visit (20+ min) | 28 | $4,977 | $79 |
| Diagnostic exam of anus using an endoscope | 12 | $1,760 | $126 |
2021: 4 services
| Return visit (30+ min) | 64 | $11,966 | $115 |
| New patient visit (45+ min) | 70 | $9,362 | $134 |
| Short return visit (20+ min) | 24 | $4,789 | $84 |
| Diagnostic exam of anus using an endoscope | 14 | $1,831 | $131 |
2020: 3 services
| Return visit (30+ min) | 34 | $4,324 | $90 |
| New patient visit (45+ min) | 28 | $3,645 | $130 |
| Short return visit (20+ min) | 16 | $1,261 | $66 |
2019: 3 services
| Return visit (30+ min) | 51 | $7,176 | $93 |
| New patient visit (45+ min) | 47 | $6,108 | $130 |
| Short return visit (20+ min) | 23 | $2,994 | $67 |
2018: 5 services
| Removal of external hemorrhoids by rubber banding | 21 | $13,543 | $246 |
| Return visit (30+ min) | 62 | $9,654 | $86 |
| New patient visit (45+ min) | 62 | $7,443 | $120 |
| Short return visit (20+ min) | 26 | $3,787 | $61 |
| Diagnostic exam of anus using an endoscope | 16 | $1,452 | $85 |
2017: 5 services
| Removal of external hemorrhoids by rubber banding | 17 | $9,428 | $242 |
| Return visit (30+ min) | 58 | $9,165 | $86 |
| New patient visit (45+ min) | 44 | $5,163 | $117 |
| Short return visit (20+ min) | 27 | $2,966 | $62 |
| Diagnostic exam of anus using an endoscope | 13 | $1,118 | $80 |
2016: 6 services
| Return visit (30+ min) | 49 | $7,698 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $6,358 | $88 |
| New patient visit (45+ min) | 42 | $5,437 | $129 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,251 | $173 |
| Short return visit (20+ min) | 14 | $1,820 | $61 |
| Diagnostic exam of anus using an endoscope | 13 | $1,110 | $85 |
2015: 7 services
| Removal of external hemorrhoids by rubber banding | 15 | $16,395 | $256 |
| Return visit (30+ min) | 50 | $7,504 | $87 |
| New patient visit (45+ min) | 40 | $5,023 | $126 |
| Short return visit (20+ min) | 22 | $4,669 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $4,482 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,796 | $164 |
| Diagnostic exam of anus using an endoscope | 18 | $1,692 | $85 |
2014: 6 services
| Removal of external hemorrhoids by rubber banding | 25 | $17,924 | $252 |
| Return visit (30+ min) | 67 | $11,173 | $95 |
| New patient visit (45+ min) | 60 | $8,367 | $139 |
| Short return visit (20+ min) | 30 | $5,094 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $4,166 | $91 |
| Diagnostic exam of anus using an endoscope | 18 | $1,816 | $86 |
2013: 6 services
| Removal of external hemorrhoids by rubber banding | 19 | $16,734 | $266 |
| Return visit (30+ min) | 78 | $13,689 | $95 |
| New patient visit (45+ min) | 69 | $9,324 | $135 |
| Short return visit (20+ min) | 27 | $4,916 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $4,902 | $89 |
| Diagnostic exam of anus using an endoscope | 15 | $1,525 | $90 |
Drugs they prescribed that Part D paid
$1,321
Pharmacies billed $1,321 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 24% of their Part D prescriptions (37 of 154) in 2024. At or below the middle of the specialty; the typical general surgery clinician is at 34%.
150 generic and fewer than 11 brand-name prescriptions · $1,321 in drug cost · 13 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Anastrozole | 18 | $284 | $16 |
| Alendronate | 26 | $228 | $9 |
| Hydrocodone-Acetaminophen | 37 | $193 | $5 |
| Losartan | 11 | $50 | $5 |
Year by year
| 2024 | 154 | 67 | 24% (37) | None | $1,321 |
| 2023 | 136 | 60 | 25% (34) | None | $1,674 |
| 2022 | 116 | 57 | 26% (30) | None | $1,351 |
| 2021 | 134 | 57 | 23% (31) | None | $2,285 |
| 2020 | 92 | 35 | 21% (19) | 14% | $2,125 |
| 2019 | 85 | 38 | 19% (16) | None | $1,562 |
| 2018 | 103 | 45 | 13% (13) | None | $7,509 |
| 2017 | 90 | 40 | 17% (15) | 12% | $6,153 |
| 2016 | 79 | 31 | None | None | $4,124 |
| 2015 | 84 | 27 | None | None | $2,817 |
| 2014 | 132 | 35 | None | None | $9,198 |
| 2013 | 185 | 33 | 7% (12) | None | $8,737 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Anastrozole | 15 | $301 | $20 |
| Hydrocodone-Acetaminophen | 34 | $240 | $7 |
| Alendronate | 21 | $230 | $11 |
| Amoxicillin-Clavulanate Potass | 17 | $112 | $7 |
2022: 4 drugs
| Levothyroxine | 12 | $273 | $23 |
| Hydrocodone-Acetaminophen | 30 | $264 | $9 |
| Anastrozole | 17 | $264 | $16 |
| Alendronate | 13 | $78 | $6 |
2021: 6 drugs
| Anastrozole | 12 | $587 | $49 |
| Tamsulosin | 21 | $276 | $13 |
| Levothyroxine | 11 | $259 | $24 |
| Hydrocodone-Acetaminophen | 31 | $256 | $8 |
| Atorvastatin | 11 | $189 | $17 |
| Amoxicillin-Clavulanate Potass | 13 | $133 | $10 |
2020: 4 drugs
| Levothyroxine | 11 | $296 | $27 |
| Anastrozole | 11 | $282 | $26 |
| Hydrocodone-Acetaminophen | 19 | $181 | $10 |
| Atorvastatin | 11 | $90 | $8 |
2019: 1 drug
| Hydrocodone-Acetaminophen | 14 | $115 | $8 |
2018: 1 drug
| Hydrocodone-Acetaminophen | 13 | $145 | $11 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 15 | $112 | $7 |
2015: 2 drugs
| Levothyroxine | 11 | $150 | $14 |
| Clopidogrel | 11 | $137 | $12 |
2013: 7 drugs
| Clopidogrel | 18 | $1,453 | $81 |
| Anastrozole | 13 | $774 | $60 |
| Atorvastatin | 18 | $626 | $35 |
| Carvedilol | 12 | $117 | $10 |
| Pantoprazole | 11 | $70 | $6 |
| Hydrocodone-Acetaminophen | 11 | $65 | $6 |
| Atenolol | 11 | $51 | $5 |
Money from drug and device companies
$5,544 in 2025
| 2025 | 1 | 5 | None | $5,544 |
| 2024 | 1 | 1 | None | $22 |
| 2020 | 8 | 8 | None | $147 |
| 2019 | 16 | 29 | None | $680 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Intuitive Surgical | Davinci Xi | $5,544 | 5 payments
|
See all 5 published payments
| Intuitive Surgical | Education · 2025-05-23 | Davinci Xi | $1,500 |
| Intuitive Surgical | Education · 2025-05-16 | Davinci Xi | $1,500 |
| Intuitive Surgical | Meals · 2025-03-26 | Da Vinci Surgical System | $28 |
| Intuitive Surgical | Meals · 2025-03-25 | Da Vinci Surgical System | $16 |
| Intuitive Surgical | Education · 2025-03-25 | Davinci Xi | $2,500 |
See earlier years (2024, 2020, 2019)
2024: $22
| Incyte | Jakafi | $22 | 1 payment
|
2020: $147
| Blueprint Medicines | Ayvakit | $25 | 1 payment
|
| Incyte | Jakafi | $23 | 1 payment
|
| Novartis Pharmaceuticals | Tasigna | $20 | 1 payment
|
| Janssen Biotech | Darzalex | $18 | 1 payment
|
| Celgene | Revlimid | $17 | 1 payment
|
| Foundation Medicine | Foundationone | $16 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $15 | 1 payment
|
| Teva Pharmaceuticals USA | Ajovy | $12 | 1 payment
|
2019: $680
| Novartis Pharmaceuticals | Votrient | $139 | 7 payments
|
| Allergan | Dalvance | $104 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | None | $86 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $53 | 3 payments
|
| Incyte | Jakafi | $38 | 2 payments
|
| Celgene | Revlimid | $34 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $34 | 2 payments
|
| Janssen Biotech | Erleada | $30 | 1 payment
|
| Amgen | Nplate | $29 | 1 payment
|
| Rigel Pharmaceuticals | Tavalisse | $26 | 1 payment
|
| Lilly USA | Erbitux | $23 | 1 payment
|
| Tesaro | Zejula | $23 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $20 | 1 payment
|
| Eisai | Halaven | $16 | 1 payment
|
| Foundation Medicine | Foundationone | $13 | 1 payment
|
| Clovis Oncology | Rubraca | $12 | 1 payment
|
Professional record
- NPI
- 1912017286
- Licence
- CA A056341
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 2485 Hospital Dr, Suite 240, Mountain View, CA, 94040
- NPI first listed
- 2006-08-30
- NPI last updated
- 2007-08-09
This is when the NPI record was last certified, not a medical board exam.